Is Fanconi anemia caused by a defect in the processing of DNA damage?

Mutation Research - DNA Repair

Volumn 408, Issue 2, 1998, Pages 75-90

  Buchwald, M ^a,b   Moustacchi, E ^a  

^a DIF   (France)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Apoptosis; Cell cycle; Cross linking agents; DNA repair; Mutagenesis

Indexed keywords

GROWTH FACTOR; MITOMYCIN C; OXYGEN;

APOPTOSIS; CELL CYCLE; DNA DAMAGE; FANCONI ANEMIA; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; MUTAGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031927305     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(98)00024-X     Document Type: Article

References (140)

1. M. Buchwald, H. Joenje, A.D. Auerbach, Fanconi anemia, in: C. Scriver, A. Beaudet, W. Sly, D. Valle (Eds.), The Metabolic and Molecular Basis of Inherited Disease, Vol. CD-Rom, McGraw-Hill, New York, 1997.
2. A. Butturini, R.P. Gale, P.C. Verlander, B. Adler-Brecher, A.P. Gillio, A.D. Auerbach, Hematological abnormalities in Fanconi anemia. An international Fanconi anemia registry study, Blood 84 (1994) 1650-1655.
3. B.P. Alter, Fanconi's anemia and malignancies, Am. J. Hematol. 53 (1996) 99-110.
4. P.F. Giampietro, P.C. Verlander, A. Maschan, J.G. Davis, A.D. Auerbach, Fanconi anemia: a model for somatic mutation during development, Am. J. Med. Genet. 52 (1994) 36-37.
5. P.F. Giampietro, B. Adler-Brecher, P.C. Verlander, S.G. Pavlakis, A.D. Auerbach, The need for some accurate and timely diagnosis in Fanconi anemia. A report from the international Fanconi anemia registry, Pediatrics 91 (1993) 1116-1120.
6. N.S. Young, B.P. Alter, Clinical features of Fanconi's anemia, in: N.S. Young, B.P. Alter (Eds.), Aplastic Anemia, Acquired and Inherited, Saunders, Philadelphia, 1994, pp. 275-324.
7. J. German, S. Schonberg, S. Caskie, D. Warburton, C. Falk, J.H. Ray, A test for Fanconi's anemia, Blood 69 (1987) 1637-1641.
8. T.M. Schroeder, F. Anschultz, A. Knoff, Spontane chromosomenaberrationen bei familier Panmyelopathie, Human-genetik 1 (1964) 194-196.
9. M.S. Sasaki, A. Tonomura, A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents, Cancer Res. 33 (1973) 1829-1836.
10. A.D. Auerbach, S.R. Wolman, Susceptibility of Fanconi's anemia fibroblasts to chromosome damage by carcinogens, Nature 261 (1976) 494-496.
11. A.D. Auerbach, A. Rogatko, T.M. Schroeder-Kurth, International Fanconi anemia registry: relation of clinical symptoms to diepoxybutane sensitivity, Blood 73 (1989) 391-396.
12. R.B. Setlow, Repair deficient human disorders and cancer, Nature 271 (1978) 713-727.
13. E.C. Friedberg, G.C. Walker, W. Siede (Eds.), DNA Repair and Mutagenesis, ASM Press, Washington, DC, 1995.
14. T.J. Jorgensen, Y. Shiloh, The ATM gene and the radiobiology of Ataxia telangiectasia, Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 69 (1996) 527-537.
15. M.F. Lavin, Y. Shiloh, Ataxia telangiectasia: a multifaceted genetic disorder associated with defective signal transduction, Curr. Opin. Immunol. 8 (1996) 459-464.
16. N. Foray, A. Priestley, G. Alsbeih, C. Badia, E.P. Capulas, C.F. Arlett, E.P. Malaise, Hypersensitivity of Ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks, Int. J. Radiat. Biol. 72 (1997) 271-283.
17. W.K. Kaufmann, R.S. Paules, DNA damage and cell cycle checkpoints, FASEB J. 10 (1996) 238-247.
18. A.G. Paulovich, D.P. Toczyski, L.H. Hartwell, When checkpoints fail, Cell 88 (1997) 315-321.
19. M. Buchwald, Complementation groups: one or more per gene? (news and views commentary), Nat. Genet. 11 (1995) 228-230.
20. H. Joenje, A.B. Oostra, M. Wijker, F.M. di Summa, C.G.M. van Berkel, M.A. Rooimans, W. Ebell, M. van Weel, J.C. Pronk, M. Buchwald, F. Arwert, Evidence for at least eight Fanconi anemia genes, Am. J. Hum. Genet. 61 (1997) 940-944.
21. C.A. Strathdee, A.M. Duncan, M. Buchwald, Evidence for at least four Fanconi anemia genes including FACC on chromosome 9, Nat. Genet. 1 (1992) 196-198.
22. C.A. Strathdee, H. Gavish, W.R. Shannon, M. Buchwald, Cloning of cDNAs for Fanconi's anemia by functional complementation, Nature 35 (1992) 763-767.
23. J.R. Lo Ten Foe, M.A. Rooimans, L. Bosnoyan-Collins, N. Alon, M. Wijker, L. Parker, J. Lightfoot, M. Carreau, D.F. Callen, A. Savoia, N.C. Cheng, C.G. van Berkel, M.H. Strunk, J.J. Grille, G. Pals, F.A. Kruyt, J.C. Pronk, F. Arwert, M. Buchwald, H. Joenje, Expression cloning of a cDNA for the major Fanconi anemia gene, FAA, Nat. Genet. 14 (1996) 320-323.
24. Fanconi anemia/Breast cancer consortium, Positional cloning of the Fanconi anemia group A gene, Nat. Genet. 14 (1996) 324-328.
25. A.D. D'Andrea, M. Grompe, Molecular biology of Fanconi anemia: implications for diagnosis and therapy, Blood 90 (1996) 1725-1736.
26. M.A. Whitney, H. Saito, P.M. Jakobs, R.A. Gibson, R.E. Moses, M. Grompe, A common mutation on the FACC gene causes Fanconi anemia in Ashkenazi Jews, Nat. Genet. 4 (1993) 202-205.
27. P.C. Verlander, J.D. Lin, M.U. Udono, Q. Zhang, R.A. Gibson, C.G. Mathew, A.D. Auerbach, Mutation analysis of the Fanconi anemia gene FACC, Am. J. Hum. Genet. 54 (1994) 595-601.
28. T. Yamashita, N. Wu, G. Kupfer, C. Corless, H. Joenje, M. Grompe, A.D. D'Andrea, Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity, Blood 87 (1996) 4424-4432.
29. A.P. Gillio, P.C. Verlander, S.D. Batish, P.F. Giampietro, A.D. Auerbach, Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an international Fanconi anemia registry study, Blood 90 (1997) 105-110.
30. F. Rosselli, J. Sanceau, J. Wietzerbin, E. Moustacchi, Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia: I. Involvement of interleukin-6, Hum. Genet. 89 (1992) 42-48.
31. F. Rosselli, J. Sanceau, E. Gluckman, J. Wietzerbin, E. Moustacchi, Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia: II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha, Blood 83 (1994) 1216-1225.
32. J.C. Schultz, N.T. Shahidi, Tumor necrosis factor-α over-production in Fanconi's anemia, Am. J. Hematol. 42 (1993) 196-201.
33. C. Diatloff-Zito, E. Duchaud, E. Viegas-Pequignot, D. Fraser, E. Moustacchi, Identification and chromosomal localization of a DNA fragment implicated in the partial correction of the Fanconi anemia group D cellular defect, Mutat. Res. 307 (1994) 33-42.
34. C. Diatloff-Zito, A.J.E. Gordon, E. Duchaud, G. Merlin, Isolation of an ubiquitously expressed cDNA encoding human dynamin II, a member of the large GTP-binding protein family, Gene 163 (1995) 301-306.
35. M. Digweed, U. Günthert, R. Schneider, H. Seyschab, R. Friedl, K. Sperling, Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene, Mol. Cell. Biol. 15 (1995) 305-314.
36. M. Jung, Y. Zhang, S. Lee, A. Dritschilo, Correction of radiation sensitivity in Ataxia telangiectasia cells by a truncated I κB-α, Science 268 (1995) 1619-1621.
37. Y. Ziv, A. Bar-Shiva, T.J. Jorgensen, P.S. Russel, A. Sartiel, T.B. Shows, R.L. Eddy, M. Buchwald, R. Legerski, R.T. Schimke, Y. Shiloh, Human cDNA clones that complement the radiomimetic sensitivity of Ataxia telangiectasia (group A) cells, Somatic Cell Mol. Genet. 21 (1995) 99-111.
38. E. Fritz, S.H. Elsea, P.I. Patel, M.S. Meyn, Overexpression of a truncated human topoisomerase III partially corrects multiple aspects of the Ataxia telangiectasia phenotype, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4538-4542.
39. S. Zakrewski, K. Sperling, Genetic heterogeneity of Fanconi's anemia demonstrated by somatic cell hybrids, Hum. Genet. 56 (1980) 81-84.
40. G. Duckworth-Rysiecki, K. Cornish, C.A. Clarke, M. Buchwald, Identification of two complementation groups in Fanconi anemia, Somatic Cell Mol. Genet. 11 (1985) 35-41.
41. P.M. Jakobs, E. Fiddler-Odell, C. Reifsteck, S. Olson, R.E. Moses, M. Grompe, Complementation group assignments in Fanconi anemia fibroblast cell lines from North America, Somatic Cell Mol. Genet. 23 (1997) 1-7.
42. H. Joenje, Fanconi anemia complementation groups in Germany and the Netherlands. European Fanconi anemia research group, Hum. Genet. 97 (1996) 280-282.
43. A. Savoia, A. Zatterale, D. Del Principe, H. Joenje, Fanconi anemia in Italy: high prevalence of complementation group A in two geographic clusters, Hum. Genet. 97 (1996) 599-603.
44. A.D. Auerbach, Fanconi anemia diagnosis and the diepoxybutane (DEB) test, Exp. Hematol. 21 (1993) 731-733.
45. R. Berger, A. Bernheim, E. Gluckman, In vitro effect of cyclophosphamide metabolites on chromosome of Fanconi anemia patients, Br. J. Haematol. 45 (1980) 565-570.
46. G. Socié, E. Gluckman, B. Raynal, T. Petit, J. Landman, A. Devergie, O. Brison, Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide/thoraco-abdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction, Blood 82 (1993) 2249-2256.
47. D.J. Stavropoulos, S. Sood, D.J. Tompkins, M. Buchwald, Correction of the spontaneous and DEB-induced chromosomal aberrations in Fanconi anemia cells of the FA(C) complementation group by the FAC gene, Cytogenet. Cell Genet. 72 (1996) 194-496.
48. R. Ishida, M. Buchwald, Susceptibility of Fanconi's anemia lymphoblasts to DNA cross-linking and alkylating agents, Cancer Res. 42 (1982) 4000-4006.
49. R. Weksberg, M. Buchwald, P. Sargent, M.W. Thompson, L. Siminovitch, Specific cellular defects in patients with Fanconi anemia, J. Cell. Phys. 101 (1979) 311-323.
50. M. Buchwald, C. Ng, J. Clarke, G. Duckworth-Rysiecki, R. Weksberg, Complementation and gene transfer studies in Fanconi anemia, in: T. Schroeder-Kurth, A.D. Auerbach, G. Obe (Eds.), Fanconi Anemia, Clinical, Cytogenetic and Experimental Aspects, Springer-Verlag, Berlin, 1989, pp. 226-235.
51. M.M. Cohen, C.E. Fruchtman, S.J. Simpson, J.A. Boughman, Chemical clastogenicity in lymphoid cell lines of chromosomal instability syndromes, Cancer Genet. Cyto-genet. 10 (1983) 267-276.
52. I. Dokal, A. Chase, N.V. Morgan, S. Couthard, G. Hall, C.G. Mathew, I. Roberts, Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anemia complementation group C mutations, Br. J. Haematol. 93 (1996) 813-816.
53. S.W. Dean, H.R. Sykes, A.R. Lehmann, Inactivation by nitrogen mustard of plasmids introduced into normal and Fanconi's anemia cells, Mutat. Res. 194 (1988) 57-63.
54. J. Coppey, M. Sala-Trepat, B. Lopez, Multiplicity reactivation and mutagenesis of trimethylpsoralen-damaged herpes virus in normal and Fanconi's anemia cells, Mutagenesis 4 (1989) 67-71.
55. C.A. Pritsos, A.C. Sartorelli, Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics, Cancer Res. 46 (1986) 3528-3532.
56. M. Tomasz, R. Lipman, D. Chowdary, J. Pawlak, G.L. Verdine, K. Nakanishi, Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA, Science 235 (1987) 1204-1208.
57. H. Borowy-Borowski, R. Lipman, M. Tomasz, Recognition between mitomycin C and specific DNA sequences for cross-link formation, Biochemistry 29 (1990) 2999-3006.
58. A.A. Clarke, N.J. Philpott, E.C. Gordon-Smith, T.R. Rutherford, The sensitivity of Fanconi anemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA cross-linking, Br. J. Haematol. 96 (1997) 240-247.
59. D. Papadopoulo, D. Averbeck, E. Moustacchi, The fate of 8-methoxypsoralen photoinduced DNA interstrand cross-links in Fanconi's anemia cells of defined genetic complementation groups, Mutat. Res. 184 (1987) 271-280.
60. Y. Fujiwara, M. Tatsumi, Cross-link repair in human cells and its possible defect in Fanconi's anemia cells, J. Mol. Biol. 113 (1977) 635-649.
61. Y. Fujiwara, Defective repair of mitomycin C cross-links in Fanconi's anemia and loss in confluent normal human and Xeroderma pigmentosum cells, Biochim. Biophys. Acta 699 (1982) 217-225.
62. G. Duckworth-Rysiecki, A.M.R. Taylor, Effects of ionizing radiation on cells from Fanconi's anemia patients, Cancer Res. 45 (1985) 416-420.
63. D. Averbeck, D. Papadopoulo, E. Moustacchi, Repair of 4,5′,8-trimethylpsoralen plus light-induced DNA damage in normal and Fanconi's anemia cell lines, Cancer Res. 48 (1988) 2015-2020.
64. S. Cheng, A. Sancar, J.E. Hearst, RecA-dependent incision of psoralen-crosslinked DNA by (A)BC excinuclease, Nucleic Acids Res. 19 (1991) 657-663.
65. N. Magana-Schwencke, J.A. Henriques, R. Chanet, E. Moustacchi, The fate of 8-methoxypsoralen photoinduced crosslinks in nuclear and mitochondrial yeast DNA: comparison of wild-type and repair-deficient strains, Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 1722-1726.
66. M. Dardalhon, D. Averbeck, Pulsed-field gel electrophoresis analysis of the repair of psoralen plus UVA induced DNA photoadducts in Saccharomyces cerevisiae, Mutat. Res. 336 (1995) 49-60.
67. J. Kaye, C.A. Smith, C.A. Hanawalt, DNA repair in human cells containing photoadducts of 8-methoxypsoralen or angelicin, Cancer Res. 40 (1980) 696-702.
68. J.L. Fendrick, L.M. Hallick, Psoralen photoinactivation of herpes simplex virus: monoadduct and cross-link repair by Xeroderma pigmentosum and Fanconi's anemia cells, J. Invest. Dermatol. 83 (1984) 968-1015.
69. P.C. Gruenert, J.E. Cleaver, Repair of psoralen-induced cross-links and monoadducts in normal and repair-deficient human fibroblasts, Cancer Res. 45 (1985) 5399-5404.
70. J.T. Reardon, P. Speilmann, J.C. Huang, S. Sastry, J.E. Hearst, A. Sancar, Removal of psoralen monoadducts and crosslinks by human cell free extracts, Nucleic Acids Res. 19 (1991) 4623-4629.
71. E. Moustacchi, C. Diatloff-Zito, DNA semi-conservative synthesis in normal and Fanconi anemia fibroblasts following treatment with 8-methoxypsoralen and near ultraviolet light or with X-rays, Hum. Genet. 70 (1985) 236-242.
72. E. Moustacchi, D. Papadopoulo, C. Diatloff-Zito, M. Buchwald, Two complementation groups of Fanconi's anemia differ in their phenotypic response to a DNA-crosslinking treatment, Hum. Genet. 75 (1987) 45-47.
73. M.M. Gök, E. Wunder, Microinjection of normal cell extracts into Fanconi anemia fibroblasts corrects defective scheduled DNA synthesis recovery after 8-methoxypsoralen plus UVA treatment, Hum. Genet. 75 (1987) 350-355.
74. M. Digweed, S. Zarewski-Lüdcke, K. Sperling, Fanconi's anemia: correlation of genetic complementation group with psoralen/UVA response, Hum. Genet. 78 (1988) 51-54.
75. M.W. Lambert, G.J. Tsongalis, W.C. Lambert, B. Hang, D.D. Parrish, Defective DNA endonuclease activities in Fanconi's anemia cells, complementation groups A and B, Mutat. Res. 273 (1992) 57-71.
76. B. Hang, A.T. Yeung, M.W. Lambert, A damage-recognition protein which binds to DNA containing interstrand cross-links is absent or defective in Fanconi anemia, complementation group A, cells, Nucleic Acids Res. 21 (1993) 4187-4192.
77. M.W. Lambert, G.J. Tsongalis, W.C. Lambert, D.D. Parrish, Correction of the DNA repair defect in Fanconi anemia complementation groups A and D cells, Biochem. Biophys. Res. Commun. 230 (1997) 587-591.
78. S. Rousset, S. Nocentini, B. Revet, E. Moustacchi, Molecular analysis by electron microscopy of the removal of psoralen-photoinduced DNA cross-links in normal and Fanconi's anemia fibroblasts, Cancer Res. 50 (1990) 2443-2448.
79. S. Rousset, S. Nocentini, R.M. Santella, F.P. Gasparro, E. Moustacchi, Immunological probing of induction and repair of 8-methoxypsoralen photoadducts in DNA from Fanconi anemia and normal human fibroblasts: quantitative analysis by electron microscopy, J. Photochem. Photobiol. B Biol. 18 (1993) 27-34.
80. S. Rousset, S. Nocentini, R.M. Santella, E. Moustacchi, 6,4,4′-trimethylangelicin photoadduct immunodetection in DNA: induction and repair in Fanconi anemia and normal human fibroblasts, J. Photochem. Photobiol. B Biol. 38 (1997) 220-227.
81. A. Matsumoto, J.M.H. Vos, P.C. Hanawalt, Repair analysis of mitomycin C induced DNA crosslinking in ribosomal RNA genes in lymphoblastoid cells from Fanconi's anemia patients, Mutat. Res. 217 (1989) 185-192.
82. E.H.A. Poll, F. Arwert, H.T. Kortbeek, A.W. Eriksson, Fanconi anemia cells are not uniformly deficient in unhooking of DNA interstrand cross-links, induced by mitomycin C or 8-methoxypsoralen plus UVA, Hum. Genel. 68 (1984) 228-234.
83. E.H.A. Poll, P.J. Abrahams, F. Arwert, A.W. Eriksson, Host-cell reactivation of cis-diamminedichloroplatinum (II)-treated SV40 DNA in normal human, Fanconi anemia and Xeroderma pigmentosum fibroblasts, Mutat. Res. 132 (1984) 181-187.
84. J.P. Rey, R. Scott, H. Müller, Induction and removal of interstrand cross-links in the ribosomal RNA genes of lymphoblastoid cell lines from patients with Fanconi anemia, Mutat. Res. 289 (1993) 171-180.
85. H. Youssoufian, Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells, J. Clin. Invest 97 (1996) 2003-2010.
86. Y. Sun, R.E. Moses, Reactivation of psoralen-reacted plasmid DNA in Fanconi anemia, Xeroderma pigmentosum and normal human fibroblast cells, Somatic Cell Mol. Genet. 17 (1991) 229-238.
87. J. Hansson, S.M. Keyse, T. Lindahl, R.D. Wood, DNA excision repair in cell extracts from human cell lines exhibiting hypersensitivity to DNA-damaging agents, Cancer Res. 51 (1991) 3384-3390.
88. A.I. Scovassi, M. Stefanini, R. Izzo, P. Lagomarsini, U. Bertazzoni, E. Moustacchi, The basal and the mutagen-induced levels of ADP-ribosyl transferase activity are not modified in Fanconi's anemia cells, Mutat. Res. 225 (1989) 65-69.
89. + ADP-ribosyl transferase (polymerizing) gene of transforming cells from a Fanconi's anemia patient, Hum. Genet. 89 (1992) 690-691.
90. M. Poot, B. Epe, H. Hoehn, Cell cycle effects of the DNA topoisomerase inhibitors camptothecin and m-AMSA in lymphoblastoid cell lines from patients with Fanconi anemia, Mutat. Res. 270 (1992) 185-189.
91. F. Rosselli, E. Duchaud, D. Averbeck, E. Moustacchi, Comparison of the effects of DNA topoisomerase inhibitors on lymphoblasts from normal and Fanconi anemia donors, Mutat. Res. 325 (1994) 137-144.
92. D. Papadopoulo, B. Porfirio, E. Moustacchi, Mutagenic response of Fanconi's anemia cells from a defined complementation group after treatment with photoactivated bifunctional psoralens, Cancer Res. 50 (1990) 3289-3294.
93. D. Papadopoulo, C. Guillouf, H. Mohrenweiser, E. Moustacchi, Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 8383-8387.
94. C. Guillouf, E. Moustacchi, D. Papadopoulo, HPRT gene expression differs in mutants derived from normal and Fanconi anemia cells: analysis of spontaneous and psoralen-photoinduced mutants, Somatic Cell Mol. Genet. 17 (1991) 591-599.
95. D. Papadopoulo, A. Laquerbe, C. Guillouf, E. Moustacchi, Molecular spectrum of mutations induced at the HPRT locus by a cross-linking agent in human cell lines with different repair capacities, Mutat. Res. 294 (1993) 167-177.
96. A. Laquerbe, E. Moustacchi, J.C. Fuscoe, D. Papadopoulo, The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 831-835.
97. C. Guillouf, A. Laquerbe, E. Moustacchi, D. Papadopoulo, Mutagenic processing of psoralen monoadducts differ in normal and Fanconi anemia cells, Mutagenesis 8 (1993) 355-361.
98. M. Escarceller, M. Buchwald, B.K. Singleton, P.A. Jeggo, S.P. Jackson, E. Moustacchi, D. Papadopoulo, Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining, J. Mol. Biol. (1998) in press.
99. S. Cohen, A. Regev, S. Lavi, Small polydispersed circular DNA (spcDNA) in human cells: association with genomic instability, Oncogene 14 (1997) 977-985.
100. B. Thygarajan, C. Campbell, Elevated homologous recombination activity in Fanconi anemia fibroblasts, J. Biol. Chem. 272 (1997) 23328-23333.
101. M. Raha, G. Wang, M.M. Seidman, P.M. Glazer, Mutagenesis by third-strand-directed psoralen adducts in repair-deficient human cells: high frequency and altered spectrum in a Xeroderma pigmentosum variant, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2941-2946.
102. A. Bredberg, Z. Sandor, M. Brant, Mutational response of Fanconi anemia cells to shuttle vector site-specific psoralen cross-links, Carcinogenesis 16 (1995) 555-561.
103. - lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors, Mutat. Res. 289 (1993) 115-126.
104. W. Ruppitsch, C. Meisslitzer, H. Weirich-Schwaiger, H. Klocker, C. Scheidereit, M. Schweiger, M. Hirsch-Kauffmann, The role of oxygen metabolism for the pathological phenotype of Fanconi anemia, Hum. Genet. 99 (1997) 710-719.
105. H. Saito, A.T. Hammond, R.E. Moses, Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells, Mutat. Res. 294 (1993) 255-262.
106. M. Foot, O. Gross, B. Epe, M. Pflaum, H. Hoehn, Cell cycle defect in connection with oxygen and iron sensitivity in Fanconi anemia lymphoblastoid cells, Exp. Cell Res. 222 (1996) 262-268.
107. H. Joenje, H. Youssoufian, F.A. Kruyt, C.C. dos Santos, R. Wevrick, M. Buchwald, Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension, Blood Cells Mol. Dis. 21 (1995) 182-191.
108. T. Takeuchi, K. Morimoto, Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency, Carcinogenesis 14 (1993) 1115-1120.
109. P. Degan, S. Bonassi, M. De Caterina, L.G. Korkina, L. Pinto, F. Scopacasa, A. Zatterale, R. Calzone, G. Pagano, In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anemia families, Carcinogenesis 16 (1995) 735-741.
110. C.E. Walsh, A.W. Nienhuis, R.J. Samulski, M.G. Brown, J.L. Miller, N.S. Young, J.M. Liu, Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector, J. Clin. Invest. 94 (1994) 1440-1448.
111. B. Dutrillaux, A. Aurias, A.M. Dutrillaux, D. Buriot, M. Prieur, The cell cycle of lymphocytes in Fanconi anemia, Hum. Genet. 62 (1982) 327-332.
112. R. Berger, M. Le Coniat, M.C. Gendron, Fanconi anemia. Chromosome breakage and cell cycle studies, Cytogenet. Cell Genet. 69 (1993) 13-16.
113. H. Seyschab, Y. Sun, R. Friedl, D. Schindler, H. Hoehn, G2 phase cell cycle disturbance as a manifestation of genetic cell damage, Hum. Genet. 92 (1993) 61-68.
114. H. Seyschab, R. Friedl, Y. Sun, D. Schindler, H. Hoehn, S. Hentze, T. Schroeder-Kurth, Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia, Blood 85 (1995) 2233-2237.
115. F. Rosselli, E. Moustacchi, Cocultivation of Fanconi anemia cells and of mouse lymphoma mutants leads to interspecies complementation of chromosomal hypersensitivity to DNA cross-linking agents, Hum. Genet. 84 (1990) 517-521.
116. G.P. Bagnara, L. Bonsi, P. Strippoli, U. Ramenghi, F. Timeus, F. Bonifazi, M. Bonafe, R. Tonelli, G. Bubola, M.F. Brizzi, L. Vitale, G. Paolucci, L. Pegoraro, V. Gabutti, Production of interleukin-6, leukemia inhibitory factor and granulocyte-macrophage colony stimulating factor by peripheral blood mononuclear cells in Fanconi's anemia, Stem Cells 11 (1993) 137-143, Suppl. 2.
117. G.P. Bagnara, P. Strippoli, L. Bonsi, M.F. Brizzi, G.C. Avanzi, F. Timeus, U. Ramenghi, G. Piaggio, J. Tong, M. Podesta, G. Paolucci, L. Pegoraro, V. Gabutti, A. Bacigalupo, Effect of stem cell factor on colony growth from acquired and constitutional (Fanconi) aplastic anemia, Blood 80 (1992) 382-387.
118. P. de Cremoux, E. Gluckman, M.P. Podgorniak, C. Menier, D. Thierry, F. Calvo, G. Socié, Decreased IL-1/β and TNFα secretion in long-term bone marrow culture supernatant from Fanconi's anemia patients, Eur. J. Haematol. 57 (1996) 202-207.
119. S.D. Lyman, M. Seaberg, R. Hanna, J. Zappone, K. Brasel, J.L. Abkowitz, J.T. Prchal, J.C. Schult, N.T. Shahidi, Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia, Blood 86 (1995) 4091-4096.
120. F.A.B. Kruyt, L.M. Dijkmans, T.K. van den Berg, H. Joenje, Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines, Blood 87 (1996) 938-948.
121. F. Rosselli, A. Ridet, T. Soussi, E. Duchaud, C. Alapetite, E. Moustacchi, p53-Dependent pathway of radio-induced apoptosis is altered in Fanconi anemia, Oncogene 10 (1995) 9-17.
122. A. Ridet, C. Guillouf, E. Duchaud, E. Cundari, M. Fiore, E. Moustacchi, F. Rosselli, Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome, Cancer Res. 57 (1997) 1722-1730.
123. J.P. Rey, R. Scott, H. Müller, Apoptosis is not involved in the hypersensitivity of Fanconi anemia cells to mitomycin C, Cancer Genet. Cytogenet. 75 (1994) 67-71.
124. G.M. Kupfer, A.D. D'Andrea, The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation, Blood 88 (1996) 1019-1025.
125. U.K. Marathi, S.R. Howell, R.A. Ashmun, T.P. Brent, The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells, Blood 88 (1996) 2298-2305.
126. W. Liebetrau, A. Budde, A. Savoia, F. Grummt, H. Hoehn, p53 Activates Fanconi anemia group C gene expression, Hum. Mol. Genet. 6 (1997) 277-283.
127. R.C. Cumming, J.M. Liu, H. Youssoufian, M. Buchwald, Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene, Blood 88 (1996) 4558-4567.
128. R.K. Rathbun, G.R. Faulkner, M.H. Ostroski, T.A. Christianson, G. Hughes, G. Jones, R. Cahn, R. Maziarz, G. Royle, W. Keeble, M.C. Heinrich, M. Grompe, P.A. Tower, G.C. Bagby, Inactivation of the Fanconi anemia group C gene augments interferon y-induced apoptotic responses in hematopoietic cells, Blood 90 (1997) 974-985.
129. M.A. Whitney, G. Royle, M.J. Low, M.A. Kelly, M.K. Axthelm, C. Reifsteck, S. Olson, R.E. Braun, M.C. Heinrich, R.K. Rathbun, G.C. Bagby, M. Grompe, Germ cell defects and hematopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the Fanconi anemia C gene, Blood 87 (1996) 49-58.
130. T. Yamashita, D.L. Barker, Y. Zhu, N. Wu, A.D. D'Andrea, The Fanconi anemia polypeptide FACC is localized to the cytoplasm, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6712-6716.
131. H. Youssoufian, A.D. Auerbach, P.C. Verlander, V. Steimle, B. Mach, Identification of cytosolic proteins that bind to the Fanconi anemia complementation group C polypeptide in vitro, J. Biol. Chem. 270 (1995) 9876-9882.
132. F.A.B. Kruyt, L.M. Dijkmans, F. Arwert, H. Joenje, Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase, Cancer Res. 57 (1997) 2244-2251.
133. G.M. Kupfer, D. Näf, A. Suliman, M. Pulsipher, A.D. D'Andrea, The Fanconi anemia proteins, FAA and FAC, interact to form a nuclear complex, Nat. Genet. 17 (1997) 487-490.
134. G.M. Kupfer, T. Yamashita, D. Näf, A. Suliman, S. Asano, A.D. D'Andrea, The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2, Blood 90 (1997) 1047-1054.
135. Y. Li, H. Youssoufian, MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups, J. Clin. Invest. 100 (1997) 2873-2880.
136. O. Levran, T. Erlich, N. Magdalena, J.J. Gregory, S. Dev Batish, P.C. Verlander, A.D. Auerbach, Sequence variation in the Fanconi anemia gene FAA, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13051-13056.
137. H. Joenje, J.R. Lo Ten Foe, A.B. Oostra, C.G. van Berkel, M.A. Rooimans, T. Schroeder-Kurth, R.D. Wegner, J.J. Gille, M. Buchwald, F. Arwert, Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype, Blood 86 (1995) 2156-2160.
138. G. Duckworth-Rysiecki, L. Toji, C. Ng, J. Clarke, M. Buchwald, Characterization of a simian virus 40-transformed Fanconi anemia fibroblast cell line, Mutat. Res. 166 (1986) 207-214.
139. N.A. Ellis, DNA helicases in inherited human disorders, Curr. Opin. Genet. Develop. 7 (1997) 354-363.
140. E. Duchaud, A. Ridet, D. Stoppa-Lyonnet, N. Janin, E. Moustacchi, F. Rosselli, Deregulated apoptosis in Ataxia telangiectasia. Association with clinical stigmata and radiosensitivity, Cancer Res. 56 (1996) 1400-1406.